Safety aspects and course of allergen-specific immunotherapy with a depigmented, polymerized allergen extract

Allergo Journal

Volumn 13, Issue 6, 2004, Pages 386-391

  Sager, Angelika ^a   Renner, Bernd G ^a  

^a LETI Pharma GmbH   (Germany)

Author keywords

Depigoid ; Efficacy; Observational cohort study; Safety; Specific immunotherapy

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; DEPIGOID; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; POLLEN EXTRACT; STEROID;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; BRONCHUS OBSTRUCTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRURITUS; RASH; RHINOCONJUNCTIVITIS; SKIN EDEMA; URTICARIA;

EID: 4744346133     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ädelroth E, Rak S, Haahtela T, Aasand G, Rosenhall L, Zetterstrom O, Byme A, Champain K, Thirlwell J, Della Cioppa G, Sandström T, Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 106: 253-9
2. Bødtger U, Poulsen LK, Jacobi HH, Malling H J. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one year, randomised, double blind, placebo controlled study. Allergy 2002; 57: 297-305
3. Boluda L, Sastre J, Casanovas M, Fernández Caldas E. Determination of Ole e 1 by enzyme immunoassay and scanning densitometry. Validation by skin prick testing. J Immunol Methods 1999; 223: 17-26
4. Bousquet J, Lockey RF, Malling H J. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53: 1-42
5. Casanovas M, Ruiz A, Gómez MJ, Basomba A, Alamar R, Fernández Caldes E, Berrens L. Skin testing with native, acid treated (depigmented) and glutaraldehyde polymerized allergen extracts of Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2001; 107: S121
6. Ferrer A, Garcia Sellés J. SIT with a depigmented, polymerized mite extract. Allergy 2002; 57: 754-5
7. Finegold I. Analyzing meta analysis of specific immunotherapy in the treatment of asthma. Ann Allergy Asthma Immunol 2001; 87: 33-7
8. Garcia Sellés J, Pascual A, Funes E, Pagán JA, López J D, Negro JM, Hernández J. Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica. Allergol Immunopathol (Madr) 2003; 31: 63-9
9. Gomez MJ, Basomba A, Alamar R, Fernández Caldas E, Casanovas M. Clinical tolerance of a modified (depigmented and glutaraldehye polymerized) allergenic extract of Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2002; 109: 1095 (Abstract)
10. Lluch M, Novalbos A, Sastre J, Gomez MJ, Fernández Caldas E, Casanovas M. Clinical tolerance of a modified (depigmented and glutaraldehyde polymerized) allergenic extract of Phleum pratense. J Allergy Clin Immunol 2002; 109: 607 (Abstract)
11. Malling H J. Immunotherapy for rhinitis. Curr Allergy Asthma Rep 2003; 3: 204-20
12. Malling H J, Weeke B. Immunotherapy position paper of the European Academy of Allergology and Clinical Immunology. Allergy 1993; 48 (Suppl 14): 9-35
13. Mellerup MT, Hahn GW, Poulsen LK, Malling H J. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side effects during induction treatment. Clin Exp Allergy 2000; 30: 1423-9
14. Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A, Jacobsen L, Koivikko A, Koller DY, Niggemann B, Norberg LA, Urbanek R, Valovirta E, Wahn U. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol 2002; 109: 251-6
15. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1: 1572-3
16. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double blind, placebo controlled studies. Clin Ther 2000; 22: 329-41
17. Walker SM, Pajno GB, Torres Lima M, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2000; 107: 87-93